Literature DB >> 17275266

Augmented reinforcer value and accelerated habit formation after repeated amphetamine treatment.

R E Nordquist1, P Voorn, J G de Mooij-van Malsen, R N J M A Joosten, C M A Pennartz, L J M J Vanderschuren.   

Abstract

Various processes might explain the progression from casual to compulsive drug use underlying the development of drug addiction. Two of these, accelerated stimulus-response (S-R) habit learning and augmented assignment of motivational value to reinforcers, could be mediated via neuroadaptations associated with long-lasting sensitization to psychostimulant drugs, i.e. augmented dopaminergic neurotransmission in the striatum. Here, we tested the hypothesis that both processes, which are often regarded as mutually exclusive alternatives, are present in amphetamine-sensitized rats. Amphetamine-sensitized rats showed increased responding for food under a random ratio schedule of reinforcement, indicating increased incentive motivational value of food. In addition, satiety-specific devaluation experiments under a random interval schedule of reinforcement showed that amphetamine-sensitized animals exhibit accelerated development of S-R habits. These data show that both habit formation and motivational value of reinforcers are augmented in amphetamine-sensitized rats, and suggest that the task demands determine which behavioral alteration is most prominently expressed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275266     DOI: 10.1016/j.euroneuro.2006.12.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  59 in total

Review 1.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

2.  Cytoskeletal determinants of stimulus-response habits.

Authors:  Shannon L Gourley; Anastasia Olevska; Jessica Gordon; Jane R Taylor
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

3.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

Review 4.  Aberrant learning and memory in addiction.

Authors:  Mary M Torregrossa; Philip R Corlett; Jane R Taylor
Journal:  Neurobiol Learn Mem       Date:  2011-03-03       Impact factor: 2.877

5.  Methamphetamine promotes habitual action and alters the density of striatal glutamate receptor and vesicular proteins in dorsal striatum.

Authors:  Teri M Furlong; Laura H Corbit; Robert A Brown; Bernard W Balleine
Journal:  Addict Biol       Date:  2017-07-14       Impact factor: 4.280

6.  Phasic mesolimbic dopamine signaling encodes the facilitation of incentive motivation produced by repeated cocaine exposure.

Authors:  Sean B Ostlund; Kimberly H LeBlanc; Alisa R Kosheleff; Kate M Wassum; Nigel T Maidment
Journal:  Neuropsychopharmacology       Date:  2014-05-07       Impact factor: 7.853

7.  Effects of prior amphetamine exposure on approach strategy in appetitive Pavlovian conditioning in rats.

Authors:  Nicholas W Simon; Ian A Mendez; Barry Setlow
Journal:  Psychopharmacology (Berl)       Date:  2008-10-11       Impact factor: 4.530

8.  The associative basis of cue-elicited drug taking in humans.

Authors:  Lee Hogarth; Anthony Dickinson; Theodora Duka
Journal:  Psychopharmacology (Berl)       Date:  2009-12-04       Impact factor: 4.530

9.  Level of operant training rather than cocaine intake predicts level of reinstatement.

Authors:  Ronald Keiflin; Caroline Vouillac; Martine Cador
Journal:  Psychopharmacology (Berl)       Date:  2007-12-27       Impact factor: 4.530

10.  Evidence for habitual and goal-directed behavior following devaluation of cocaine: a multifaceted interpretation of relapse.

Authors:  David H Root; Anthony T Fabbricatore; David J Barker; Sisi Ma; Anthony P Pawlak; Mark O West
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.